Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study

BACKGROUND: Metastatic breast cancer (mBC) is a heterogenous disease with increasing availability of targeted therapies as well as emerging genomic markers of therapeutic resistance, necessitating timely and accurate molecular characterization of disease. As a minimally invasive test, analysis of ci...

Descripción completa

Detalles Bibliográficos
Autores principales: Zivanovic Bujak, Andjelija, Weng, Chen-Fang, Silva, Maria João, Yeung, Miriam, Lo, Louisa, Ftouni, Sarah, Litchfield, Cassandra, Ko, Yi-An, Kuykhoven, Keilly, Van Geelen, Courtney, Chandrashekar, Sushma, Dawson, Mark A., Loi, Sherene, Wong, Stephen Q., Dawson, Sarah-Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529214/
https://www.ncbi.nlm.nih.gov/pubmed/33001984
http://dx.doi.org/10.1371/journal.pmed.1003363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529214/
https://www.ncbi.nlm.nih.gov/pubmed/33001984
http://dx.doi.org/10.1371/journal.pmed.1003363

Ejemplares similares